15
Participants
Start Date
August 31, 2006
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
Dual Growth Factor
"10,000 IU Beta-hCG IV on days 1, 3, and 5 of study participation~30,000 IU Erythropoietin IV on days 7, 8 and 9 of study participation"
University of California, Irvine Medical Center, Orange
Stem Cell Therapeutics Corp.
INDUSTRY
Hoag Memorial Hospital Presbyterian
OTHER
University of California, Irvine
OTHER